Vaxcyte, Inc. (PCVX)
NASDAQ: PCVX · Real-Time Price · USD
55.96
+2.98 (5.62%)
Jul 30, 2026, 4:00 PM EDT - Market closed
Vaxcyte Stock Forecast
Stock Price Forecast
According to 11 analysts polled by S&P Global, Vaxcyte stock has a consensus rating of "Strong Buy" and an average price target of $109. The average 1-year stock price forecast is 94.78% higher than the current stock price, while the lowest is $67 (+19.73%) and the highest is $163 (+191.28%).
Price Target: $109 (+94.78%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Vaxcyte stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 9 | 9 | 9 | 9 | 9 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 11 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Buy Maintains $89 | Buy | Maintains | $89 | +59.04% | Jul 30, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $116 | Buy | Maintains | $116 | +107.29% | Jul 14, 2026 |
| Needham | Needham | Buy Maintains $110 | Buy | Maintains | $110 | +96.57% | Jun 26, 2026 |
| Mizuho Securities | Mizuho Securities | Buy Maintains $163 | Buy | Maintains | $163 | +191.28% | Jun 18, 2026 |
| Evercore ISI | Evercore ISI | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 21, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
87.15M
EPS This Year
-8.48
from -5.63
EPS Next Year
-7.42
from -8.48
EPS and Forward PE are based on non-GAAP adjusted numbers.